Surgery, Gastroenterology and Oncology
Official journal of the International Association of Surgeons, Gastroenterologists and Oncologists
|
|
Can Gastric Specimen Measurements Defines the Laparoscopic Sleeve Gastrectomy Outcome?
Background: It is a matter of search that resected gastric specimen measurements (RGSM) has an effect on weight loss following LSG. The aim of this study was to investigate the influence of RGSM on weight loss at 3-6-12 months after LSG.
Methods: 64 Patients who underwent LSG between 2014-2018 at Marmara University Hospital were enrolled. The LSG procedure and RGSMs were performed using standardized techniques. Patients were followed-up every 3 months in the first year. Correlations between the percentages of excess weight losses (EWL) at 3rd, 6th, 12th months and RGSMs were evaluated.
Results: No major complication was seen. Mean body mass index (BMI) at 1 year after LSG was significantly lower than the baseline BMI 50.4Â+-8.4 kg m2 versus 31 +-6.1 kg m2; P=0.001). Mean % EWLs -3rd, -6th, -12th months were 39%, 59%, 75%, respectively.
Resected gastric volume (RGV) was 803.28+-37.2 mL. Expansibility on resection line (LRL-e) was 17.2 +-1.3 %. There was no correlation between RGV and % EWL at 3-6-12 mo. However, the % EWL-12 mo. was correlated with LRL-e (r=0,514, p=0,014).
Conclusion: There is a positive correlation between 12th mo EWL% and LRL-e of resected specimen. This may bea harbinger of good weight loss during the theatre.
Full Text Sources:
Abstract:
Views: 3790
Methods: 64 Patients who underwent LSG between 2014-2018 at Marmara University Hospital were enrolled. The LSG procedure and RGSMs were performed using standardized techniques. Patients were followed-up every 3 months in the first year. Correlations between the percentages of excess weight losses (EWL) at 3rd, 6th, 12th months and RGSMs were evaluated.
Results: No major complication was seen. Mean body mass index (BMI) at 1 year after LSG was significantly lower than the baseline BMI 50.4Â+-8.4 kg m2 versus 31 +-6.1 kg m2; P=0.001). Mean % EWLs -3rd, -6th, -12th months were 39%, 59%, 75%, respectively.
Resected gastric volume (RGV) was 803.28+-37.2 mL. Expansibility on resection line (LRL-e) was 17.2 +-1.3 %. There was no correlation between RGV and % EWL at 3-6-12 mo. However, the % EWL-12 mo. was correlated with LRL-e (r=0,514, p=0,014).
Conclusion: There is a positive correlation between 12th mo EWL% and LRL-e of resected specimen. This may bea harbinger of good weight loss during the theatre.
Full Text Sources:
Abstract:
Views: 3790
Watch Video Articles
For Authors
Journal Subscriptions
Current Issue
Dec 2025
Supplements
Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)
e-ISSN: 2601 - 1700 (online)
ISSN-L: 2559 - 723X
Journal Abbreviation: Surg. Gastroenterol. Oncol.
Surgery, Gastroenterology and Oncology (SGO) is indexed in:
e-ISSN: 2601 - 1700 (online)
ISSN-L: 2559 - 723X
Journal Abbreviation: Surg. Gastroenterol. Oncol.
Surgery, Gastroenterology and Oncology (SGO) is indexed in:
- SCOPUS
- EBSCO
- DOI/Crossref
- Google Scholar
- SCImago
- Harvard Library
- Open Academic Journals Index (OAJI)
Open Access Statement
Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.
Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.
Journal Metrics
Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2
Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2
IASGO Society News
Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.